SI-BONE, Inc.
SIBN Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 23, 2026
$21.48
KIRA · Stoqly’s AI analyst, in plain words
- SI-BONE, Inc. had $201M of revenue in fiscal 2025, up 20.2% on the year before. Over five years, revenue changed +22.3% a year on average.
- Its operating margin was −11.1%, up 10.0 pts: of every 100 in sales, about −11 is left after running the business.
- SI-BONE, Inc. lost $18.9M in fiscal 2025.
- Free cash flow was −$9.1M in fiscal 2025, −4.5% of revenue.
- SI-BONE, Inc. has $6.7M more cash than debt.
Market cap
$955M
P/E
—
Revenue
$201M
Net income
−$18.9M
Free cash flow
−$9.1M
Operating margin
−11.1%
SI-BONE, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+20.2%
Yes. Sales grew 20.2% last year.
Does it make a profit?
−9.4%
No. It lost money last year.
Does profit turn into cash?
−4.5%
No. It spent more cash than it brought in.
How healthy are the accounts?
6 / 9
Mixed. It passes 6 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What SI-BONE, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 24, 2026
- Legal name
- SI-BONE, Inc.
- CIK
- 0001459839
SI-BONE, Inc. · SIBN
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $90.2M | $106M | $139M | $167M | $201M |
| Revenue growth | 22.8% | 18.0% | 30.5% | 20.4% | 20.2% |
| Gross margin | 88.4% | 85.2% | 78.8% | 79.0% | 79.6% |
| Operating margin | −57.3% | −56.0% | −33.8% | −21.1% | −11.1% |
| Net income | −$56.6M | −$61.3M | −$43.3M | −$30.9M | −$18.9M |
| Net margin | −62.8% | −57.6% | −31.2% | −18.5% | −9.4% |
| Diluted EPS | −$1.71 | −$1.79 | −$1.13 | −$0.75 | −$0.44 |
| Cash | |||||
| Cash from operations | −$39.5M | −$41.7M | −$18.7M | −$12.4M | −$0.7M |
| Capital expenditure | $6.4M | $9.5M | $7.8M | $10.5M | $8.4M |
| Free cash flow | −$45.9M | −$51.2M | −$26.5M | −$22.9M | −$9.1M |
| FCF margin | −50.9% | −48.1% | −19.1% | −13.7% | −4.5% |
| Share count change | 14.1% | 3.2% | 12.4% | 7.9% | 3.6% |
| Debt and strength | |||||
| Cash and short-term investments | $147M | $97.3M | $33.3M | $34.9M | $42.2M |
| Debt incl. finance leases | $35.0M | $35.2M | $36.1M | $35.5M | $35.6M |
| Shareholders' equity | $134M | $98.3M | $169M | $167M | $178M |
| Current ratio | 10.4x | 6.5x | 9.0x | 7.7x | 8.5x |
| Interest coverage | −9.6x | −21.1x | −13.6x | −10.2x | −8.5x |
| Returns and quality | |||||
| Return on capital | −182.1% | −130.1% | −21.5% | −16.6% | −10.3% |
| Return on equity | −37.2% | −52.6% | −32.4% | −18.4% | −11.0% |
| Return on tangible equity | −42.1% | −62.3% | −25.6% | −18.5% | −10.6% |
| Piotroski F-score | 3 | 2 | 4 | 5 | 6 |
| Altman Z'' | 1.1 | −3.3 | 1.2 | 0.8 | 1.5 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$11.8M
7 insiders
Of sales under plans
66%
$7.8M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
SI-BONE, Inc. · SIBN
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $21.48 a share, the company is worth $955M.
Source: SEC EDGAR XBRL filings (CIK 0001459839). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.